Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 20 04:00PM ET
6.83
Dollar change
+0.38
Percentage change
5.89
%
IndexRUT P/E- EPS (ttm)-1.37 Insider Own59.93% Shs Outstand17.42M Perf Week2.71%
Market Cap125.40M Forward P/E- EPS next Y-1.41 Insider Trans0.10% Shs Float7.36M Perf Month14.21%
Income-22.38M PEG- EPS next Q-0.31 Inst Own8.53% Short Float15.84% Perf Quarter-21.94%
Sales0.00M P/S- EPS this Y9.79% Inst Trans28.38% Short Ratio14.45 Perf Half Y-19.17%
Book/sh0.76 P/B8.94 EPS next Y-9.30% ROA-124.61% Short Interest1.17M Perf Year-62.06%
Cash/sh1.06 P/C6.44 EPS next 5Y- ROE-170.23% 52W Range5.85 - 18.29 Perf YTD-18.11%
Dividend Est.- P/FCF- EPS past 5Y- ROI-159.62% 52W High-62.66% Beta0.45
Dividend TTM- Quick Ratio3.46 Sales past 5Y0.00% Gross Margin- 52W Low16.75% ATR (14)0.57
Dividend Ex-Date- Current Ratio3.46 EPS Y/Y TTM4.05% Oper. Margin0.00% RSI (14)53.03 Volatility6.65% 9.19%
Employees13 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price22.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q8.40% Payout- Rel Volume1.05 Prev Close6.45
Sales Surprise- EPS Surprise36.98% Sales Q/Q- EarningsMay 07 BMO Avg Volume80.67K Price6.83
SMA204.66% SMA502.39% SMA200-21.54% Trades Volume84,309 Change5.89%
Date Action Analyst Rating Change Price Target Change
Jul-13-22Initiated Ladenburg Thalmann Buy $21
May-28-24 06:10AM
May-24-24 09:55AM
May-16-24 08:30AM
May-07-24 09:06PM
01:53PM
08:00AM Loading…
08:00AM
Apr-08-24 08:30AM
Apr-02-24 04:30PM
Mar-19-24 08:00AM
Mar-15-24 08:00AM
Mar-14-24 09:00AM
Mar-05-24 11:52PM
08:31AM
08:00AM
Feb-09-24 08:32AM
08:00AM Loading…
08:00AM
Jan-03-24 08:00AM
Dec-18-23 08:00AM
Nov-08-23 08:00AM
Oct-24-23 08:00AM
Oct-16-23 09:35AM
Sep-25-23 07:30PM
Sep-21-23 08:00AM
Sep-12-23 08:00AM
Sep-06-23 08:00AM
Sep-01-23 08:00AM
Aug-17-23 08:00AM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 08:00AM
06:26AM Loading…
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
07:23AM
Jul-20-23 06:55AM
06:55AM
Jul-19-23 07:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
06:50AM
Jul-13-23 07:02AM
07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
06:08AM
Jul-10-23 06:56AM
06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 07:13AM
06:58AM
Jun-27-23 06:46AM
06:46AM
Jun-26-23 06:41AM
Jun-21-23 07:20AM
Jun-20-23 08:00AM
06:35AM
Jun-18-23 08:03AM
Jun-05-23 08:50AM
Jun-01-23 04:48AM
May-31-23 06:22AM
May-19-23 08:50AM
May-15-23 09:55AM
08:00AM
May-10-23 08:00AM
May-09-23 01:34PM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 10:14AM
08:00AM
06:47AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-18-23 08:00AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 08:00AM
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChairman & CEOMay 14 '24Buy6.741,94013,0763,246,424May 15 09:16 AM
BENTSUR RONChairman & CEOMay 10 '24Buy6.402,00012,8003,244,484May 13 08:51 AM
Shemesh ShayChief Dev. & Ops. OfficerMay 10 '24Buy6.321,1137,0341,493,068May 13 08:47 AM
Poradosu EnriqueChief Science & Business OffMay 10 '24Buy6.295003,1451,504,319May 13 08:49 AM
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM
BENTSUR RONChairman & CEOOct 10 '23Buy11.086407,0913,237,484Oct 12 04:05 PM
BENTSUR RONChairman & CEOOct 09 '23Buy11.198309,2883,236,844Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 06 '23Buy11.272502,8183,236,014Oct 10 08:30 AM
BENTSUR RONChairman & CEOOct 05 '23Buy11.091,40015,5263,235,764Oct 06 08:37 AM
BENTSUR RONChairman & CEOOct 04 '23Buy10.951,82019,9293,234,364Oct 06 08:37 AM
BENTSUR RONChairman & CEOAug 16 '23Buy15.151151,7423,232,544Aug 16 04:05 PM
BENTSUR RONChairman & CEOAug 15 '23Buy14.342353,3703,232,429Aug 16 04:05 PM
BENTSUR RONChairman & CEOAug 11 '23Buy14.661802,6393,232,194Aug 11 06:07 PM
BENTSUR RONChairman & CEOAug 08 '23Buy14.831201,7803,232,014Aug 11 06:07 PM
Mosseri Marlio Charles10% OwnerJul 31 '23Buy13.8886011,9372,595,000Aug 01 08:00 AM
Mosseri Marlio Charles10% OwnerJul 28 '23Buy13.912,58435,9432,594,140Jul 31 08:00 AM
Mosseri Marlio Charles10% OwnerJul 27 '23Buy13.981,55621,7532,591,556Jul 28 08:00 AM
Mosseri Marlio Charles10% OwnerJul 26 '23Buy13.9710,000139,7002,590,000Jul 27 06:52 AM
Mosseri Marlio Charles10% OwnerJul 21 '23Buy14.612,84441,5512,580,000Jul 24 04:45 PM
BENTSUR RONChairman & CEOJul 21 '23Buy14.852253,3413,231,894Jul 24 04:45 PM
Mosseri Marlio Charles10% OwnerJul 20 '23Buy14.405,39477,6742,577,156Jul 24 04:45 PM
BENTSUR RONChairman & CEOJul 20 '23Buy15.061101,6573,231,669Jul 24 04:45 PM
Mosseri Marlio Charles10% OwnerJul 19 '23Buy14.848,000118,7202,571,762Jul 20 06:30 AM
BENTSUR RONChairman & CEOJul 19 '23Buy14.332002,8663,231,559Jul 20 06:30 AM
Mosseri Marlio Charles10% OwnerJul 18 '23Buy14.849,149135,7712,563,762Jul 19 08:06 AM
BENTSUR RONChairman & CEOJul 14 '23Buy15.031502,2543,231,359Jul 18 08:34 AM
Mosseri Marlio Charles10% OwnerJul 12 '23Buy15.093,28549,5712,554,613Jul 13 08:30 AM
Mosseri Marlio Charles10% OwnerJul 11 '23Buy15.3610,000153,6002,551,328Jul 12 08:30 AM
Mosseri Marlio Charles10% OwnerJul 07 '23Buy15.198,948135,9202,541,328Jul 10 08:00 AM
BENTSUR RONChairman & CEOJul 07 '23Buy16.191101,7813,231,209Jul 18 08:34 AM
Mosseri Marlio Charles10% OwnerJul 06 '23Buy15.013,17947,7172,532,380Jul 07 08:04 AM
BENTSUR RONChairman & CEOJul 06 '23Buy14.883204,7623,231,099Jul 07 08:03 AM
Mosseri Marlio Charles10% OwnerJul 05 '23Buy15.521,17618,2522,529,201Jul 06 07:45 AM
Mosseri Marlio Charles10% OwnerJun 26 '23Buy16.4616,760275,8702,528,025Jun 27 08:45 AM
BENTSUR RONChairman & CEOJun 26 '23Buy16.5075012,3753,230,779Jun 27 08:45 AM
Mosseri Marlio Charles10% OwnerJun 23 '23Buy17.4373,1751,275,4402,511,265Jun 26 08:45 AM
Mosseri Marlio Charles10% OwnerJun 22 '23Buy17.736,999124,0922,438,090Jun 23 08:59 AM
Last Close
Jun 20 04:00PM ET
1.31
Dollar change
+0.05
Percentage change
3.97
%
XAIR Beyond Air Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-2.11 Insider Own17.99% Shs Outstand45.90M Perf Week4.80%
Market Cap60.13M Forward P/E- EPS next Y-1.75 Insider Trans-0.34% Shs Float37.65M Perf Month0.00%
Income-66.70M PEG- EPS next Q-0.47 Inst Own36.59% Short Float9.33% Perf Quarter-14.94%
Sales0.69M P/S87.14 EPS this Y-3.98% Inst Trans10.31% Short Ratio11.02 Perf Half Y-21.08%
Book/sh0.59 P/B2.23 EPS next Y9.65% ROA-105.99% Short Interest3.51M Perf Year-78.84%
Cash/sh0.69 P/C1.91 EPS next 5Y- ROE-185.90% 52W Range1.06 - 6.36 Perf YTD-33.16%
Dividend Est.- P/FCF- EPS past 5Y9.16% ROI-179.27% 52W High-79.40% Beta-0.02
Dividend TTM- Quick Ratio3.26 Sales past 5Y-54.80% Gross Margin-395.86% 52W Low23.58% ATR (14)0.11
Dividend Ex-Date- Current Ratio3.39 EPS Y/Y TTM-25.60% Oper. Margin-9341.22% RSI (14)55.11 Volatility6.67% 8.90%
Employees98 Debt/Eq0.81 Sales Y/Y TTM- Profit Margin-9680.99% Recom1.00 Target Price12.60
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q-17.28% Payout- Rel Volume0.72 Prev Close1.26
Sales Surprise-12.96% EPS Surprise7.41% Sales Q/Q- EarningsJun 24 AMC Avg Volume318.65K Price1.31
SMA207.51% SMA504.88% SMA200-26.64% Trades Volume230,471 Change3.97%
Date Action Analyst Rating Change Price Target Change
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Jun-13-24 04:05PM
Jun-03-24 07:00AM
May-23-24 04:09PM
May-01-24 07:00AM
Mar-21-24 12:00PM
09:00AM Loading…
Mar-20-24 09:00AM
Feb-13-24 08:51AM
Feb-12-24 04:05PM
Jan-18-24 08:00AM
Dec-27-23 07:30AM
Dec-21-23 01:40AM
Nov-15-23 04:05PM
Nov-14-23 10:00AM
Nov-13-23 04:05PM
Nov-03-23 12:00PM
04:05PM Loading…
Oct-19-23 04:05PM
Oct-17-23 04:05PM
07:30AM
Oct-16-23 07:30AM
07:00AM
Oct-04-23 07:30AM
Oct-02-23 04:05PM
Sep-27-23 09:00AM
Sep-18-23 04:05PM
Sep-07-23 07:30AM
Sep-06-23 07:00AM
Aug-10-23 04:05PM
Aug-08-23 09:55AM
Aug-07-23 04:05PM
Aug-01-23 04:05PM
10:13AM Loading…
Jul-28-23 10:13AM
Jul-24-23 04:05PM
Jun-22-23 04:05PM
Jun-15-23 04:10PM
04:05PM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-02-23 06:56AM
Jun-01-23 06:29AM
May-31-23 06:40AM
May-30-23 06:50AM
May-26-23 06:59AM
May-25-23 06:38AM
May-24-23 06:43AM
May-23-23 06:33AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 06:39AM
May-17-23 06:35AM
May-16-23 04:05PM
Apr-19-23 09:00AM
Mar-31-23 06:36AM
Mar-23-23 04:05PM
Mar-14-23 04:35PM
Mar-10-23 07:04AM
Feb-22-23 07:00AM
Feb-09-23 04:05PM
Jan-30-23 07:00AM
Jan-24-23 04:05PM
Jan-17-23 04:05PM
Dec-13-22 09:25AM
Nov-17-22 04:05PM
Nov-10-22 09:00AM
Nov-08-22 04:05PM
Oct-24-22 07:30AM
Oct-20-22 04:05PM
Oct-17-22 04:05PM
Oct-05-22 08:00AM
Oct-03-22 07:30AM
Sep-16-22 04:05PM
Aug-23-22 08:00AM
Aug-11-22 04:05PM
Jul-27-22 04:05PM
Jun-28-22 04:10PM
04:05PM
Jun-14-22 04:30PM
Jun-01-22 07:00AM
May-17-22 04:05PM
07:00AM
May-16-22 07:05AM
May-06-22 06:29AM
Apr-25-22 04:05PM
07:00AM
Apr-18-22 07:00AM
Apr-11-22 07:00AM
Mar-08-22 04:35PM
Feb-22-22 04:52AM
Feb-10-22 04:05PM
Feb-08-22 08:00AM
Feb-03-22 04:05PM
Jan-27-22 08:00AM
Dec-14-21 09:15AM
Dec-10-21 09:14AM
Dec-09-21 08:30AM
05:56AM
Dec-01-21 08:00AM
Nov-18-21 04:05PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avniel AmirChief Business OfficerDec 28 '23Sale2.0513,73328,2170Dec 29 04:23 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0611,26723,234685,760Dec 29 04:23 PM
Myers Jeff LynnChief Medical OfficerDec 27 '23Sale2.213,4237,57946,577Dec 29 04:15 PM
Carey RobertDirectorDec 18 '23Buy1.641,200,0001,962,0002,374,454Dec 19 05:13 PM
Lisi Steven A.CEO and Chairman of the BoardDec 18 '23Buy1.6377,775126,7971,536,471Dec 19 05:15 PM
Gaul Michael A.Chief Operating OfficerNov 16 '23Buy1.7710,00017,70088,150Nov 17 04:15 PM
Carey RobertDirectorAug 28 '23Buy2.69250,000673,7501,225,160Aug 29 04:10 PM
Carey RobertDirectorAug 21 '23Buy2.7675,050207,453975,160Aug 22 04:10 PM
Carey RobertDirectorAug 18 '23Buy2.6413,61435,940900,110Aug 22 04:10 PM
Gaul Michael A.Chief Operating OfficerJun 30 '23Buy4.515,00022,55078,150Jul 05 04:05 PM